Editor LSA

Volume Actives: NPS Pharmaceuticals, Lululemon Athletica Inc. (NASDAQ:LULU), Vertex Pharmaceuticals Incorporated, Microchip Technology Inc

 

Lewes, DE -- (SBWIRE) -- 10/31/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), Lululemon Athletica inc. (NASDAQ:LULU), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Microchip Technology Inc. (NASDAQ:MCHP).

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), decreased -7.43% and closed at $27.30 on a traded volume of 2.70 million shares, in comparison to 2.22 million shares of average trading volume. So far this year, the stock is up over 200%.The company has a total market capitalization of $2.77Billion and its total outstanding shares are 101.43 million.

Will NPSP Get Buyers Even After The Recent Rally? Find Out Here

NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapeutic products in the United States. Its lead product is Gattex for the treatment of adult patients with short bowel syndrome (SBS) who are dependent on parenteral support.

Lululemon Athletica inc. (NASDAQ:LULU), plunged -3.52% and closed at $70.67 on a traded volume of 2.70 million shares, whereas its average trading volume is 2.34 million shares. In the last three months, the stock is up1.58%. The Intra-day range for the stock is $70.31 and $73.40.

Has LULU Found The Bottom and Ready To Move Up? Find Out Here

lululemon athletica inc., together with its subsidiaries, designs, manufactures, and distributes athletic apparel and accessories for women, men, and female youth. It operates in three segments: Corporate-Owned Stores, Direct To Consumer, and Other.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), dropped down -5.70% and closed at $71.75. So far in three months, the stock is up down -10.09%. The 52-week range for the stock is $38.44 and $89.96 and during the previous trading session it marked$75.37 as its highest price. The stock initially exchanged hands with a price of $74.97 and the overall traded volume that day was 2.69 million shares.

Has VRTX Found The Bottom And Ready To Gain Momentum? Find Out Here

Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases.

Microchip Technology Inc. (NASDAQ:MCHP), after opening its shares at the price of $40.40, dropped -0.86% to close the day at $39.95. The stock ended on a traded volume of 2.71 million shares, in comparison to 1.55 million shares of average trading volume. The 52-week range for the stock is $28.92 and $41.78 and during the previous trading session the stock scored the highest price of $40.60. It started the day at $40.40.

Will MCHP Get Buyers Even After The Recent Rally? Find Out Here

Microchip Technology Incorporated engages in developing, manufacturing, and selling semiconductor products for embedded control applications.

About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/